How Long Does Shingles Last? Stages and Timeline

A typical episode of shingles runs its course in roughly two to five weeks, from the earliest warning signs through complete healing of the skin. The rash itself tends to resolve in about ten to fifteen days once blisters appear, though pain can start days before any visible rash and, in unlucky cases, linger for months or years afterward as a condition called postherpetic neuralgia. The timeline varies considerably depending on your age, immune health, how quickly you start antiviral treatment, and where on the body the rash appears.

Before the Rash Appears

Shingles usually announces itself with a prodromal phase, a stretch of days where you feel something wrong but have nothing to show for it. Pain, burning, tingling, or itching crops up along one side of the body, typically in a band or strip following the path of a single nerve. This prodrome usually lasts three to five days before the characteristic blistering rash breaks out.¹ Some people also experience fatigue, headache, or a low-grade fever during this window, though not everyone does.

The tricky part is that this pain can mimic all sorts of other problems. When the prodrome hits the torso, people sometimes think they are having a heart attack or gallbladder trouble. When it strikes the lower back or leg, it can look like a herniated disc. One documented case involved a man in his seventies whose prodromal pain in his right leg led doctors to investigate lumbar spinal stenosis for two full weeks before the rash finally appeared and revealed the true cause.¹ Extended prodromal periods like that are unusual but not unheard of, and they can delay both diagnosis and antiviral treatment.

The Active Rash

Once the prodrome ends, clusters of small, fluid-filled blisters erupt on reddened skin. They typically appear in a band on one side of the body, most commonly on the trunk, though the face, neck, and limbs are all fair game. New blisters can continue forming for three to five days. During this window the pain is usually at its worst, and the fluid inside the blisters contains live varicella-zoster virus, meaning you can transmit chickenpox (though not shingles itself) to someone who has never had chickenpox or been vaccinated against it.

Over the next week or so, the blisters cloud over, break open, and begin to dry out. Within about ten to fifteen days of appearing, the lesions generally crust over and start to heal.² You are considered no longer contagious once every blister has formed a dry scab. In most people, the scabs fall off within another one to two weeks, sometimes leaving behind patches of lighter or darker skin that may take a few additional months to fade.

How Antivirals Affect the Timeline

The standard advice is to start an antiviral medication (acyclovir, valacyclovir, or famciclovir) within 72 hours of the rash appearing. These drugs do not kill the virus outright, but they stop it from replicating, which tends to shorten the active rash phase, reduce the severity of blisters, and lower the odds of lingering pain afterward. Starting treatment even a day or two late still helps, but the benefit shrinks with each passing day. If you are past the 72-hour window and still forming new blisters, most clinicians will still prescribe antivirals, since the virus is clearly still active.

Antivirals cannot cut the timeline to zero. Even with prompt treatment, expect at least two weeks from rash onset to full crusting. What the medication really buys you is a reduction in peak severity and a lower chance of complications, particularly the chronic nerve pain that is the most feared aftermath of shingles.

When Pain Outlasts the Rash

For a substantial number of people, the skin heals but the pain does not go away. This is postherpetic neuralgia, defined as pain persisting for at least three months after the rash resolves, though in some individuals it lasts for years.³ The pain can be constant and burning, intermittent and stabbing, or provoked by light touch on the skin, like clothing brushing against it. Some people experience all three types at once.

PHN can significantly disrupt daily life, interfering with sleep, mood, and the ability to perform routine tasks. Older adults are hit hardest. A large meta-analysis of over 124,000 participants found that people aged 60 to 69 had roughly double the odds of developing PHN compared with younger patients, while those over 70 had about triple the odds.⁴ Beyond age, several other factors raised the risk: a severe initial rash, intense acute pain during the blister phase, a history of anxiety or depression, diabetes, cancer, and chronic lung disease all showed significant associations in pooled analyses.⁴

Separate research reached similar conclusions from a different angle, finding that older age, female sex, the presence of a prodrome before the rash, greater rash severity, and greater acute pain severity each independently predicted who would go on to develop PHN.⁵ In short, if your shingles episode was particularly painful and covered a large area, your risk of prolonged pain is meaningfully higher.

Managing Postherpetic Neuralgia

If PHN develops, the treatment approach shifts from antivirals (which are no longer useful once the virus has stopped replicating) to pain management. First-line options typically include certain antidepressants and anticonvulsants that dampen nerve signaling, as well as topical treatments like lidocaine patches applied directly over the painful area. For people who do not respond to those, stronger options exist, including opioid-class pain medications and nerve blocks.

One treatment that has shown promise for stubborn PHN is a high-concentration capsaicin patch, which is applied to the painful skin area by a clinician. A real-world registry study of PHN patients found that average pain intensity dropped from about 62 out of 100 at baseline to about 47 at three months and roughly 32 at twelve months with repeated treatments. Patients who received four treatments over the year had the most dramatic reductions, while those who stopped treatment saw their improvements fade.⁶ Quality of life, sleep, and mood all tracked the same pattern, improving with ongoing treatment and worsening when it was stopped. PHN management, in other words, often requires patience and sustained effort rather than a single fix.

What Happens When Shingles Hits the Eye

Shingles involving the ophthalmic branch of the trigeminal nerve, called herpes zoster ophthalmicus (HZO), follows the same general rash timeline as shingles elsewhere but carries additional risks that can extend the medical timeline well beyond the skin healing. About half of patients with HZO develop some form of eye involvement, and among those, up to a quarter go on to develop chronic or recurrent eye disease.⁷ Common problems include inflammation of the clear front surface of the eye, inflammation inside the eye itself, and conjunctivitis.

A study of nearly 870 HZO patients found that close to half developed uveitis, an inflammation inside the eye, with a median onset about ten days after the rash first appeared. Among those examined within the first week of rash onset, roughly one in six already had uveitis at their first eye exam, and an additional quarter were diagnosed at a follow-up visit.⁸ Eyes with uveitis had higher rates of vision loss, corneal scarring, elevated eye pressure, glaucoma, and cataracts, but prompt antiviral treatment was associated with a lower rate of moderate vision loss.⁸

The practical takeaway is straightforward: if you develop shingles blisters on your forehead, around your eye, or on the tip of your nose (which is supplied by the same nerve branch), you need an eye exam, even if your vision seems fine at first. Eye complications from HZO can appear days to weeks after the rash and may require months of follow-up with an ophthalmologist.

When Shingles Affects the Ear

Ramsay Hunt syndrome occurs when shingles reactivates in the nerve serving the ear and part of the face. The signature combination is painful blisters in or around the ear canal along with facial paralysis on the same side, sometimes accompanied by hearing loss, ringing in the ear, or dizziness. This is one of the more alarming presentations because facial paralysis can feel devastating.

The good news is that recovery rates for facial function are reasonably encouraging. A review of 882 patients with Ramsay Hunt syndrome found that about 70% achieved good or near-normal facial recovery. Even among patients who presented with complete facial paralysis, roughly half eventually recovered to a good functional level.⁹ One case report documented a patient with the most severe grade of facial nerve paralysis who recovered to near-normal function within two weeks of starting combined antiviral and corticosteroid therapy.¹⁰ Speed of treatment matters here just as it does with standard shingles. The sooner antivirals and steroids are started, the better the chances of full recovery.

Secondary Infections and Delayed Healing

Open blisters are a doorway for bacteria, and while secondary bacterial infection of the shingles rash is uncommon, it does happen, particularly in people who scratch at the blisters or have weakened immune systems. When bacteria colonize the damaged skin, the affected area can become redder, more swollen, and more painful, and the healing timeline stretches out.¹¹ In rare cases, the infection involves antibiotic-resistant bacteria like MRSA, which complicates treatment further.

Keeping the rash clean and covered, avoiding scratching, and watching for signs of worsening redness or pus are the simplest ways to prevent this complication. If you notice the rash area becoming increasingly hot, red, or swollen after the first week, or if you develop a new fever after the initial illness seemed to be improving, see a clinician. A bacterial superinfection does not change the underlying viral course, but it can add weeks to skin healing and leave worse scarring.

Can You Get Shingles More Than Once

A common misconception is that shingles is a one-time event. The virus remains in your nerve cells for life, and while a first episode does provide some immune boosting, recurrences happen. Studies estimate that roughly one to ten percent of people who have had shingles will experience it again, with an incidence rate of about two to seventeen cases per thousand person-years across general populations.¹² Those are wide ranges partly because different studies tracked different populations over different lengths of time, but the bottom line is that a second episode is not rare enough to dismiss.

Recurrent shingles can show up on the same side and dermatome as the first episode, or on a completely different part of the body. People who are immunosuppressed face a higher recurrence risk, as do those whose first episode was especially severe. Vaccination after a first episode is generally recommended, since the recombinant zoster vaccine can substantially reduce the risk of a repeat episode regardless of whether you have already had shingles.

Why the Virus Reactivates in the First Place

After you recover from chickenpox, varicella-zoster virus does not leave your body. Instead, it travels along nerve fibers to clusters of nerve cells called ganglia, where it enters a dormant state. The virus can sit quietly for decades, held in check by your immune system. Research using human stem-cell-derived neurons has shown that the virus enters through the ends of nerve fibers, travels to the cell bodies, and establishes a quiet infection without producing detectable levels of its typical active-infection proteins.¹³

Reactivation occurs when the immune surveillance holding the virus in check weakens. Aging is the most powerful trigger, since immune function naturally declines over the decades. Stress, illness, immunosuppressive medications, and conditions like HIV can also tip the balance. The exact molecular switches involved are still being worked out. Laboratory models have identified several signaling pathways that appear to play a role in controlling the transition between dormancy and active replication, but the full picture remains incomplete, partly because the virus is uniquely human-specific and does not behave the same way in animal models.¹⁴

Who Faces a Rougher Course

Not everyone’s shingles episode follows the same clock. Several factors consistently predict a longer, more severe, or more complicated course:

Age: Older adults heal more slowly, experience more intense pain, and are far more likely to develop PHN. The jump in risk accelerates after age 60.
Immune suppression: People on chemotherapy, organ transplant recipients on anti-rejection drugs, and those with HIV or other immune-compromising conditions tend to have more widespread rashes and slower recovery.
Rash location: Shingles on the face carries extra risks, including eye and ear complications described above, and tends to receive more aggressive treatment as a result.
Rash severity: A larger area of blistering at the outset predicts both a longer acute phase and a greater likelihood of chronic pain afterward.
Delay in treatment: Starting antivirals more than 72 hours after the rash appears is associated with a more prolonged course and higher complication rates.

Advanced age, severe acute pain during the rash, extensive rash involvement, prodromal pain before the rash, and immunocompromised status have all been consistently flagged across multiple large reviews as the major predictors of PHN specifically.¹⁵ If you fall into several of these categories, your clinician may monitor you more closely and consider earlier intervention for pain management.

A Rough Timeline at a Glance

Putting it all together, here is what a typical, uncomplicated shingles episode looks like in time:

Days 1–5: Prodromal pain, tingling, or burning on one side of the body. No visible rash yet.
Days 3–8: Blisters appear in a band or cluster. New blisters may keep forming for several days.
Days 7–12: Blisters begin to cloud over, rupture, and dry into crusts.
Days 10–15: Crusts are forming over most or all lesions. Pain usually begins to taper.
Weeks 3–5: Scabs fall off, leaving behind pink or discolored skin. Most people feel significantly better.

This timeline compresses for younger, healthier individuals who start antivirals promptly, and stretches for older or immunocompromised patients. Skin discoloration at the rash site can persist for weeks to months even after all the scabs are gone, but this is a cosmetic concern rather than a sign of ongoing infection.

Vaccination and the Recombinant Zoster Vaccine

The most effective way to shorten or avoid the shingles timeline altogether is vaccination. The recombinant zoster vaccine (sold as Shingrix) is recommended for adults 50 and older and for younger adults with compromised immune systems. While randomized trials have not shown a significant difference in vaccine effectiveness between age groups, real-world studies show a general trend toward somewhat lower protection against shingles with increasing age, both in the short and long term.¹⁶ Even with that age-related decline, the vaccine remains highly effective across all studied age groups and also reduces the risk of PHN among those who do get breakthrough shingles. If you had shingles in the past and are wondering whether vaccination still makes sense, the answer is yes: the vaccine is recommended even for people with a prior episode, since it lowers the chance of recurrence.

1
PubMed Central. Extended Prodromal Period in Herpes Zoster: A Case Report and Management Implications
2
PubMed Central. Healing of Severe Herpes Zoster Ophthalmicus Within a Few Days: An Autobiographical Case Report
3
PubMed Central. Postherpetic neuralgia in the elderly
4
PubMed Central. New Findings on Risk Factors for Postherpetic Neuralgia From 2014 to 2024: A Systematic Review and Meta-Analysis
5
PubMed. Risk factors for postherpetic neuralgia in patients with herpes zoster
6
PubMed Central. Progressive Improvements with Repeated High-Concentration Capsaicin Patch: Real-World Data from the Retrospective CASPAR German Pain e-Registry Study in Postherpetic Neuralgia
7
PubMed Central. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention
8
PubMed. Herpes Zoster Ophthalmicus Uveitis: Onset and Complications
9
PubMed Central. Treatment and Prognosis of Facial Palsy on Ramsay Hunt Syndrome: Results Based on a Review of the Literature
10
PubMed Central. Rapid Resolution of Grade VI Facial Nerve Paralysis in Ramsay Hunt Syndrome With Prompt Dual Antiviral‐Corticosteroid Therapy: A Case Report
11
PubMed Central. Clinical Management of Herpes Zoster Complicated by MRSA Infection
12
PubMed Central. Herpes Zoster Recurrence: A Narrative Review of the Literature
13
PLOS Pathogens. An In Vitro Model of Latency and Reactivation of Varicella Zoster Virus in Human Stem Cell-Derived Neurons
14
PubMed Central. Current In Vitro Models to Study Varicella Zoster Virus Latency and Reactivation
15
PubMed Central. Current advances in the epidemiology, risk factors, prevention, management, and long-term outcomes of herpes zoster and post-herpetic neuralgia
16
PubMed Central. Efficacy and Effectiveness of the Recombinant Zoster Vaccine Against Herpes Zoster, Herpes Zoster Ophthalmicus, Postherpetic Neuralgia and Dementia: A Systematic Review and Meta‐Analysis